Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Hepatitis Therapeutics Industry?
In recent times, there has been a steady expansion in the hepatitis therapeutics market size. This growth is projected to continue, increasing from $18.66 billion in 2024 to $19.08 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 2.2%. Factors contributing to this growth in the historic period include developments in vaccines, antiviral medications, public health initiatives, research funding, and the emergence of new therapies.
Expectations suggest a consistent expansion in the hepatitis therapeutics market size in the upcoming years. It is projected to reach “$22.32 billion by 2029 with a compound annual growth rate (CAGR) of 4.0%. The anticipated progress during the forecast duration is due to the persistence of research and development, worldwide health initiatives, transition in patient care, governmental programs, and increasing awareness of the disease. During this forecast period, there is likely to be an emphasis on patient advocacy and backing, constant monitoring and follow-up, health care fairness, telemedicine and distant care, as well as a focus on the elimination of hepatitis C.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9956&type=smp
What Forces Are Driving The Growth Of The Hepatitis Therapeutics Industry?
The global increase in hepatitis infection is predicted to drive the expansion of the hepatitis therapeutic market. This increase is primarily due to limited healthcare accessibility and vaccination, increased intravenous drug usage, unsafe blood transfusion methods, and unsatisfactory sanitation and hygiene standards in certain regions of the world. For example, in April 2022, the World Health Organization (WHO), a US-based United Nations public health organization, reported that 169 cases of acute hepatitis of indeterminate cause had been recorded across 11 countries, and 350 million people globally have either hepatitis B or C. However, majority of them still lack access to testing and treatment. Consequently, the upsurge in hepatitis infection is driving the growth of the hepatitis therapeutic market.
What Is The Overview Of Market Segmentation In The Hepatitis Therapeutics Industry?
The hepatitis therapeutics market covered in this report is segmented –
1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types
2) By Drug Class: Oral Antivirals, Immune Modulators
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
Subsegments:
1) By Hepatitis A: Vaccines, Post-Exposure Prophylaxis (PEP)
2) By Hepatitis B: Antiviral Medications, Immune Modulators, Vaccines
3) By Hepatitis C: Direct-Acting Antivirals (DAAs), Ribavirin, Interferon-Based Therapies
4) By Other Disease Types: Hepatitis D, Hepatitis E, Other Viral Hepatitis Infections
What Upcoming Trends Are Expected To Impact The Hepatitis Therapeutics Market Globally?
Product advancements are becoming a leading trend in the hepatitis therapeutics market. Crucial players in this sector, such as Gilead Sciences, Inc., are making strides in new product development to solidify their market standing. For example, in November 2022, this US-based biopharmaceutical company obtained FDA approval for Vemlidy (tenofovir alafenamide), a medicine designed for treating pediatric patients with chronic hepatitis B virus infection. Initially approved by the FDA in 2016, Vemlidy is a specially formulated prodrug of tenofovir intended for once-daily treatment of individuals with chronic hepatitis B virus (HBV) infection and compensated liver disease. As recommended by the American Liver Foundation, it is primarily recommended for those with chronic HBV and compensated liver disease.
Who Are The Primary Players Operating Across The Global Hepatitis Therapeutics Market?
Major companies operating in the hepatitis therapeutics market include Gilead Sciences Inc., Bristol-Myers Squibb Co., AbbVie Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Cipla Inc., F Hoffmann-La Roche Ltd., Biocon Limited, LAURUS Labs Ltd., Zydus Lifesciences Limited, Hetero Healthcare Limited, Novartis AG, Sanofi SA, GlaxoSmithKline plc, Lupin Ltd., Teva Pharmaceutical Industries Ltd., NATCO Pharma Limited, Pfizer Inc., AstraZeneca plc, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Biocon Biopharmaceuticals Pvt. Ltd.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report
Which Region Offers The Most Growth Potential For The Hepatitis Therapeutics Market Through 2029?
North America was the largest region in the hepatitis therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the hepatitis therapeutics market report during the forecast period. The regions covered in the hepatitis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9956&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model